EU doctors urge gamete donor cap across borders

A leading European fertility organisation is calling for a shared, cross-border cap on how many families can be formed using gametes from a single donor, arguing that today’s fragmented national rules cannot reliably prevent extreme outcomes.

Officials involved in the initiative say the is to reduce risks that grow when one donor’s sperm or eggs lead to very large numbers of donor-conceived people across multiple countries. They point to concerns about accidental consanguinity and the possibility that an undetected genetic mutation could be passed widely before it is identified.

Why national limits are failing in a cross-border market Regulations across Europe differ sharply, with some countries applying strict caps while others set higher limits or use different counting methods. The organisation says these differences become harder to manage when clinics and banks import and export gametes across borders.

Because donor material can move between jurisdictions, enforcement of any single country’s cap may not reflect the total number of families created from the same donor across Europe. Supporters of the proposal say this gap in oversight makes it possible for a single donor to be used far more widely than intended.

Proposed caps range from 50 families to 15

Proponents argue that a Europe-wide ceiling of 50 families per donor should be adopted as an initial baseline. Some experts backing the push have also suggested tightening the limit further to 15 families , reflecting a more cautious approach to both medical and social risks.

The initiative follows documented cases in which individual donors have been linked to hundreds of births . Backers say such outcomes can create complex psychological questions for donor-conceived people, alongside medical issues that become harder to track as genetic links spread across countries and clinics.

Regulatory hurdles and unintended consequences

Supporters acknowledge that implementing a shared cap would face major regulatory challenges. Gametes are routinely traded across borders, and oversight standards are not uniform, which can complicate reliable counting and consistent monitoring.

There is also concern, according to those involved, that rules perceived as too restrictive could push some prospective parents toward unregulated donation channels. They warn this could increase legal uncertainty and health risks if donors are not appropriately screened.

For now, the organisation is positioning a transnational limit as a first step toward reducing the most severe cases, while recognising that enforcement, cross-border coordination, and safeguards against illicit markets would be central to any workable policy.